3-DESOXYNALTREXONE
UNII MY8R2RWA7P

Substance Identification & Data

This profile provides standardized clinical and technical data for 3-desoxynaltrexone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MY8R2RWA7P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 152659-61-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
MY8R2RWA7P
CAS Registry Number
152659-61-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
3-DESOXYNALTREXONE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C20H23NO3
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
SUPMBXSJDVIFQJ-BTHPGYMESA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c1cc2C[C@@H]3[C@@]4(CCC(=O)[C@H]5[C@]4(CCN3CC6CC6)c2c(c1)O5)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 3-desoxynaltrexone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

3-DESOXYNALTREXONE

Systematic Nomenclature

(5.ALPHA.)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-14-HYDROXYMORPHINAN-6-ONE
17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-14-HYDROXYMORPHINAN-6-ONE, (5.ALPHA.)-
MORPHINAN-6-ONE, 17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-14-HYDROXY-, (5.ALPHA.)-